Muhammad Ajmal Khan

8PUBLICATIONS

43CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 22, 2026

Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo.

|Mar 16, 2026

TNIK overexpression is sufficient for chemoradiation resistance in limited-stage small cell lung cancer.

Dipanwita Dutta Chowdhury, Eddie L Imada, Nick Connis

|Jun 10, 2024

TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.

Triet Nguyen, Francesca A Carrieri, Nick Connis

|Apr 26, 2024

TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.

Triet Nguyen, Francesca A Carrieri, Nick Connis

|Jan 21, 2023

Recent Advances in Genomics-Based Approaches for the Development of Intracellular Bacterial Pathogen Vaccines.

Muhammad Ajmal Khan, Aftab Amin, Awais Farid

|Jan 04, 2023

An essential Noc3p dimerization cycle mediates ORC double-hexamer formation in replication licensing.

Aftab Amin, Rentian Wu, Muhammad Ajmal Khan

Pageof 2

Frequent Collaborators

Audrey Lafargue

Jinhee Chang

Phuoc T Tran

Triet Nguyen

Francesca Anna Carrieri

Nick Connis

Aaron Chan

Amol C Shetty

Yang Song

Dipanwita Dutta Chowdhury

Frequent Collaborators

Audrey Lafargue

Jinhee Chang

Phuoc T Tran

Triet Nguyen